IMC Chicago’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
IMC Chicago's MDGL Position: Q3 2026 in Review
IMC Chicago reduced its Madrigal Pharmaceuticals (MDGL) stake by 30% in Q3 2026, selling an estimated $1.72M and leaving 7,594 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2486.
IMC Chicago first reported a position in MDGL in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.02M in Q4 2025. 440 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- IMC Chicago held 7,594 shares of Madrigal Pharmaceuticals worth $3.83M as of Q3 2026.
- IMC Chicago sold 3,253 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $1.72M.
- Madrigal Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2486 holding.
- IMC Chicago first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- IMC Chicago's Madrigal Pharmaceuticals position peaked at $7.02M in Q4 2025.
- 440 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.